All Stories

By exercising long-held stock options, BioNTech CEO scored €260M payday in 2024

In exercising some of his stock options in 2024, BioNTech CEO Uğur Şahin, M.D., scored a whopping 259.5 million euros in calculated compensation, the company said in its annual report.

Mar 10, 2025 - 20:46
 0
By exercising long-held stock options, BioNTech CEO scored €260M payday in 2024
In exercising some of his stock options in 2024, BioNTech CEO Uğur Şahin, M.D., scored a whopping 259.5 million euros in calculated compensation, the company said in its annual report.
Read More

Tags:

Previous Article

Like Consumers, Many Beauty Investors Love Dupes

Next Article

J&J opts out of licensing Genmab's Darzalex challenger after look at phase 1/2 data

Related Posts

As Xarelto's decline picks up speed, Bayer doesn't expect pharma growth until 2027

As Xarelto's decline picks up speed, Bayer doesn't expe...

Mar 5, 2025  0

With $27B plan to build 4 new plants, Eli Lilly doubles down on US drug manufacturing

With $27B plan to build 4 new plants, Eli Lilly doubles...

Feb 26, 2025  0

AstraZeneca, Daiichi unblind Enhertu study early as star ADC helps stomach cancer patients live longer

AstraZeneca, Daiichi unblind Enhertu study early as sta...

Mar 3, 2025  0